BRD7 Gene - Bromodomain Containing 7

A key regulator in chromatin remodeling and tumor suppression

Gene Information Card

Symbol BRD7
Full Name Bromodomain Containing 7
Gene Type Protein coding
Chromosomal Location 16q12.1
NCBI Gene ID 29117 ncbi.nlm.nih.gov/gene/29117
Ensembl ID ENSG00000166164
UniProt ID Q9NPI1
OMIM ID 612541
HGNC ID 14310
Aliases BP75, CELTIX1, NAG4

Description

BRD7 (Bromodomain Containing 7) encodes a protein that contains a bromodomain, a structural motif characteristic of proteins involved in chromatin remodeling and transcriptional regulation. BRD7 acts as a tumor suppressor by modulating chromatin structure and gene expression, particularly in pathways related to cell cycle control, apoptosis, and DNA damage response. It is frequently downregulated or mutated in various cancers, including breast, ovarian, and nasopharyngeal carcinoma.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer Loss of BRD7 expression leads to increased cell proliferation and invasion via dysregulation of chromatin remodeling and estrogen receptor signaling. PMID: 23542344; COSMIC
Nasopharyngeal carcinoma BRD7 acts as a tumor suppressor; reduced expression correlates with poor prognosis and enhanced tumor growth. PMID: 18413744; NCBI Gene
Ovarian cancer BRD7 mutations and decreased expression contribute to oncogenesis through impaired DNA repair and cell cycle regulation. PMID: 25691885; COSMIC
Hepatocellular carcinoma BRD7 downregulation promotes metastasis and epithelial-mesenchymal transition (EMT). PMID: 29057924

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Brain 8.2 Low
Breast 6.1 Low
Ovary 5.8 Low
Liver 4.3 Low
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 7.2 Moderate expression
HeLa (cervical cancer) 6.8 Moderate expression
HepG2 (liver cancer) 5.1 Low expression
A549 (lung cancer) 4.9 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1012C>T (p.Arg338*) Nonsense <1% Loss of function; truncated protein
c.1456G>A (p.Glu486Lys) Missense <1% Unknown functional impact
c.789_790insA Frameshift <1% Loss of function; predicted protein truncation
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., p.Arg338*, c.789_790insA) result in truncated or absent BRD7 protein, impairing its tumor suppressor activity.

Gain of Function (GOF)

No gain-of-function mutations reported in BRD7.

Dominant Negative (DN)

No dominant-negative mutations documented for BRD7.

Gene Ontology (GO)

• chromatin binding • protein binding
• transcription coactivator activity • nucleus
• chromatin remodeling • negative regulation of cell proliferation
• DNA repair

Pathways

• Chromatin remodeling
• p53 signaling pathway
• Cell cycle - G1/S transition
• DNA damage response

Protein Summary

BRD7 is a 651-amino acid protein containing a bromodomain that recognizes acetylated lysine residues on histones, facilitating chromatin remodeling and transcriptional regulation. It interacts with components of the SWI/SNF complex and p53, playing a critical role in tumor suppression by controlling cell cycle progression, apoptosis, and DNA repair. BRD7 is widely expressed, with highest levels in testis, and is frequently lost or mutated in human cancers.

Related Products

Product name Cat.No. Species Gene ID
BRD7 Knockout HEK293 Cell Line EDJ-KQ51237 Human 29117 Details Get a Quote
BRD7 Knockout HeLa Cell Line EDJ-KQ56101 Human 29117 Details Get a Quote
BRD7 Knockout A-549 Cell Line EDJ-KQ64587 Human 29117 Details Get a Quote
BRD7 Knockout HCT 116 Cell Line EDJ-KQ73041 Human 29117 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: